Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N -chelating ligand

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Organometallic Chemistry

• Publication date

  2010-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JORGANCHEM.2010.01.020
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Bimetallic ruthenium–tin chemistry: Synthesis and molecular structure of arene ruthenium complexes containing trichlorostannyl ligands

  2010cited by this paper
• Arene ruthenium complexes as anticancer agents.

  2010cited by this paper
• Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.

  2009cited by this paper
• Functionalised η6-arene ruthenium complexes

  2009cited by this paper
• Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft

  2009cited by this paper
• Recent developments in ruthenium anticancer drugs.

  2009cited by this paper
• Design of nickel chelates of tetradentate N-heterocyclic carbenes with subdued cytotoxicity

  2009cited by this paper
• Bioorganometallic chemistry--from teaching paradigms to medicinal applications.

  2009cited by this paper
• DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media.

  2009cited by this paper
• Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin.

  2009cited by this paper
• Influence of the Arene Ligand, the Number and Type of Metal Centers, and the Leaving Group on the in Vitro Antitumor Activity of Polynuclear Organometallic Compounds

  2009cited by this paper
• Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.

  2009cited by this paper
• Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.

  2009cited by this paper
• Water-Soluble Mixed-Ligand Ruthenium(II) and Osmium(II) Arene Complexes with High Antiproliferative Activity

  2008cited by this paper
• The ruthenium(II)–arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53–JNK pathways

  2008cited by this paper
• Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.

  2008cited by this paper
• Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.

  2008cited by this paper
• Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound.

  2008cited by this paper
• A short history of SHELX.

  2008cited by this paper
• Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach.

  2008cited by this paper
• High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.

  2008cited by this paper
• Bioorganometallic fulvene-derived titanocene anti-cancer drugs.

  2008cited by this paper
• Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: relevance to antitumour activity.

  2008cited by this paper
• Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds.

  2008cited by this paper
• Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.

  2008cited by this paper
• Cytotoxic half-sandwich rhodium(III) complexes: Polypyridyl ligand influence on their DNA binding properties and cellular uptake

  2008cited by this paper
• Resistance against novel anticancer metal compounds: differences and similarities.

  2008cited by this paper
• Ferrocifens and ferrocifenols as new potential weapons against breast cancer

  2007cited by this paper
• (η5-Pentamethylcyclopentadienyl)Rhodium and -Iridium Compounds

  2007cited by this paper
• Mono and dinuclear rhodium, iridium and ruthenium complexes containing chelating 2,2′-bipyrimidine ligands: Synthesis, molecular structure, electrochemistry and catalytic properties

  2007cited by this paper
• 16. (η6‐Hexamethylbenzene)Ruthenium Complexes

  2007cited by this paper
• Coligand tuning of the DNA binding properties of half-sandwich organometallic intercalators : Influence of polypyridyl (pp) and monodentate ligands (L = Cl, (NH2)2CS, (NMe2)2CS) on the intercalation of (η5 -pentamethylcyclopentadienyl )-iridium(iii)-dipyridoquinoxaline and -dipyridophenazine complex

  2007cited by this paper
• The design of organometallic ruthenium arene anticancer agents

  2007cited by this paper
• Highly Antiproliferative Ruthenium(II) and Osmium(II) Arene Complexes with Paullone-Derived Ligands

  2007cited by this paper
• Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

  2007cited by this paper
• The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.

  2007cited by this paper
• Water-soluble arene ruthenium catalysts containing sulfonated diamine ligands for asymmetric transfer hydrogenation of α-aryl ketones and imines in aqueous solution

  2007cited by this paper
• Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy

  2006cited by this paper
• Metal-based antitumour drugs in the post genomic era.

  2006cited by this paper
• Water‐Soluble Arene Ruthenium Complexes Containing a trans‐1,2‐Diaminocyclohexane Ligand as Enantioselective Transfer Hydrogenation Catalysts in Aqueous Solution

  2005cited by this paper
• Cationic arene ruthenium complexes containing chelating 1,10-phenanthroline ligands

  2005cited by this paper
• Binding of Organometallic Ruthenium(II) and Osmium(II) Complexes to an Oligonucleotide: A Combined Mass Spectrometric and Theoretical Study

  2005cited by this paper
• Development of organometallic (organo‐transition metal) pharmaceuticals

  2005cited by this paper
• In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.

  2005cited by this paper
• A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

  2004cited by this paper
• Bioorganometallic Chemistry: Structural Diversity of Organometallic Complexes with Bioligands and Molecular Recognition Studies of Several Supramolecular Hosts with Biomolecules, Alkali-Metal Ions, and Organometallic Pharmaceuticals

  2003cited by this paper
• Transfer hydrogenation of a variety of ketones catalyzed by rhodium complexes in aqueous solution and their application to asymmetric reduction using chiral Schiff base ligands

  2003cited by this paper
• pH-Dependent Transfer Hydrogenation of Ketones with HCOONa as a Hydrogen Donor Promoted by (η6-C6Me6)Ru Complexes

  2002cited by this paper
• In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

  2002cited by this paper
• Review: Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of the Free University of Brussels

  2002cited by this paper
• Inhibition of cancer cell growth by ruthenium(II) arene complexes.

  2001cited by this paper
• pH-Dependent Transfer Hydrogenation of Water-Soluble Carbonyl Compounds with [Cp*IrIII(H2O)3]2+ (Cp* = η5-C5Me5) as a Catalyst Precursor and HCOONa as a Hydrogen Donor in Water

  1999cited by this paper
• Synthesis and characterization of Cp∗Rh (III) and Ir (III) polypyridyl complexes:

  1998cited by this paper
• ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI)

  1997cited by this paper
• Synthesis and structure of [(η-C5Me5)Ir(CO)]2

  1990cited by this paper
• Highly fluxional arene cyclooctatetraene complexes of zerovalent iron, ruthenium, and osmium. Single-crystal x-ray study of (cyclooctatetraene)(hexamethylbenzene)ruthenium(0), Ru(.eta.6HMB)(1-4-.eta.-COT)

  1980cited by this paper
• Arene ruthenium(II) complexes formed by dehydrogenation of cyclohexadienes with ruthenium(III) trichloride

  1974cited by this paper
• Benzene Complexes of Ruthenium(II)

  1972cited by this paper
• Pentamethylcyclopentadienylrhodium and -iridium halides. I. Synthesis and properties

  1969cited by this paper

• Cytotoxic Organometallic Iridium(III) Complexes

  2025cites this paper
• A comprehensive survey of cytotoxic active half-sandwich Ir(III) complexes: structural perspective, and mechanism of action.

  2025cites this paper
• Metallotherapeutic complexes with high selective properties for anti-neoplastic therapy

  2024cites this paper
• Rhodium complex [RhLI2]I: a novel anticancer agent inducing tumor inhibition and apoptosis

  2024cites this paper
• Copper(II) complexes containing hydrazone and bipyridine/phenanthroline ligands for anticancer application against breast cancer cells.

  2024cites this paper
• Platinum group metal (PGM) complexes having acylthiourea ligand system as catalysts or anticancer agents

  2024cites this paper
• Design and construction of novel pyridine-pyrimidine hybrids as selective COX-2 suppressors: anti-inflammatory potential, ulcerogenic profile, molecular modeling and ADME/Tox studies

  2023cites this paper
• Antimicrobial study of ruthenium and iridium half-sandwich complexes containing fluorenyl hydrazonothiazole derivative ligands

  2023cites this paper
• Synthesis and in vitro anticancer studies of arene ruthenium(II) and arene osmium(II) complexes bearing arsine and stibine co-ligands on breast cancer cell-lines.

  2023cites this paper
• Half-sandwich iridium(III) and rhodium(III) complexes: synthesis, characterization and antifouling properties

  2023cites this paper
• Synthesis, structural characterization and anticancer properties of p-cymene Ru(II) complexes with 2-(N-methyl-1H-1,2,4-triazol-3-yl)pyridines

  2022cites this paper
• New Rh(III) chloro complex of a tetradentate S-picolyl azo ligand of acetyl acetone: Synthesis, X-ray structure, spectral characterization, electrochemistry, DFT computation and interaction with DNA

  2022cites this paper
• Anticancer Half-Sandwich Rhodium(III) Complexes

  2021cites this paper
• Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

  2021cites this paper
• Transition metal complexes of ligand 4-imino-3-[(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)diazenyl]-4H pyrimido[2,1-b][1,3]benzothiazol-2-ol containing benzothiazole moiety: Synthesis, spectroscopic characterization and biological evaluation

  2021cites this paper
• Synthetic strategies, crystal structures and biological activities of metal complexes with the members of azole family: A review

  2021cites this paper
• Synthesis, molecular structure, anti-microbial, anti-oxidant and enzyme inhibition activities of 2-amino-6-methylbenzothiazole and its Cu(II) and Ag(I) complexes

  2020cites this paper
• Direct fluorogenic detection of palladium and platinum organometallic complexes with proteins and nucleic acids in polyacrylamide gels

  2020cites this paper
• Facile synthesis of heterobimetallic [FeII(µ-diphosphine)RuII] and homobimetallic [FeII(µ-diphosphine)FeII] complexes and their in vitro cytotoxic activity on cisplatin-resistant cancer cells

  2020cites this paper
• Facile entry to germanate and stannate complexes [(η6-arene)RuCl(η2-dppm)]+[ECl3]- (E = Ge, Sn) as potent anti-cancer agents

  2020cites this paper
• Crystal Structure, Antitumour and Antibacterial Activity of Imidazo[1, 2‐α]pyridine Ligand Containing Palladium Complexes

  2020cites this paper
• Metallocomplex-Peptide Interactions Studied by Ultra-High Resolution Mass Spectrometry.

  2020cites this paper
• Synthesis, Structure and Antioxidant Activity of Mixed Ruthenium(III) Benzoyl Pyridine Complex

  2020cites this paper
• Amidation of aldehydes using mono-cationic half-sandwich rhodium(III) complexes with functionalized phenylhydrazone ligands

  2019cites this paper
• Synthesis, characterisation and cytotoxicity studies of ruthenium arene complexes bearing trichlorogermyl ligands

  2019cites this paper
• Antimicrobial selectivity of ruthenium, rhodium, and iridium half sandwich complexes containing phenyl hydrazone Schiff base ligands towards B. thuringiensis and P. aeruginosa bacteria

  2019cites this paper
• Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium(ii)–arene-2-heteroarylbenzoxazole complexes

  2019cites this paper
• Synthesis of Thiourea and Guanidine Derivatives and Testing for Biological Activity

  2019cites this paper
• Organometallic Iridium Arene Compounds: The Effects of C-Donor Ligands on Anticancer Activity

  2019cites this paper
• Half-sandwich Ru(η6-p-cymene) complexes featuring pyrazole appended ligands: Synthesis, DNA binding and in vitro cytotoxicity.

  2019cites this paper
• Anticancer study of heterobimetallic platinum(II)-ruthenium(II) and platinum(II)-rhodium(III) complexes with bridging dithiooxamide ligand

  2019cites this paper
• Modulation of the solubility properties of arene ruthenium complexes bearing stannyl ligands as potential anti-cancer agents

  2019cites this paper
• Microfocus x-ray fluorescence mapping of tumour penetration by an organo‑osmium anticancer complex.

  2018cites this paper
• Investigation of anticancer properties of caffeinated complexes via computational chemistry methods.

  2018cites this paper
• Using a Hydrogen‐Bonded Rosette‐Type Scaffold to Generate Heteronuclear Metalla‐Assemblies

  2018cites this paper
• p-Cymene Ruthenium Halide Complexes with a Heterocyclic Carbene

  2018cites this paper
• Novel iridium(III) iminopyridine complexes: synthetic, catalytic, and in vitro anticancer activity studies

  2018cites this paper
• Half Sandwich Rhodium(III) and Iridium(III) Complexes as Cytotoxic and Metallonuclease Agents

  2018cites this paper
• Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.

  2018cites this paper
• Pre-clinical evaluation of novel inorganic compounds as potential anticancer therapies

  2018cites this paper
• Further insights into ruthenium(II) piano-stool complexes with N-alkyl imidazoles

  2018cites this paper
• Dual-functional cyclometalated iridium imine NHC complexes: highly potent anticancer and antimetastatic agents

  2018cites this paper
• Lysosome-targeted potent half-sandwich iridium(III) α-diimine antitumor complexes

  2018cites this paper
• Pyrazole Based Mono- and Di-Substituted Half Sandwich d6 Platinum Group Metal Complexes: Synthesis and Spectral Characterization

  2018cites this paper
• Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands.

  2018cites this paper
• The discovery of half-sandwich iridium complexes containing lidocaine and (pyren-1-yl)ethynyl derivatives of phenylcyanamide ligands for photodynamic therapy.

  2017cites this paper
• Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.

  2017cites this paper
• Investigation of the coordination chemistry of multidentate azine Schiff-base ligands towards d6 half-sandwich metal complexes

  2017cites this paper
• Synthesis and In Vitro (Anticancer) Evaluation of eta(6)-Arene Ruthenium Complexes Bearing Stannyl Ligands

  2017cites this paper
• Synthesis, Structural Characterization, and Biological Evaluation of Novel Substituted 1,3‐Thiazole Derivatives Containing Schiff Bases

  2017cites this paper
• Rhodium (II) complex with 2-benzoylpyridine, a novel potential chemotherapeutic drug, induces cell cycle arrest and apoptosis in HepG2 cells

  2017cites this paper
• Coordination chemistry of thiazoles, isothiazoles and thiadiazoles

  2016cites this paper
• In‐Cell Activation of Organo‐Osmium(II) Anticancer Complexes

  2016cites this paper
• Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes.

  2016cites this paper
• Synthesis, structural, DFT calculations and biological studies of rhodium and iridium complexes containing azine Schiff-base ligands

  2016cites this paper
• Amberlite IR-120(H)-mediated “on water” synthesis of novel anticancer ruthenium(II)–p-cymene 2-pyridinylbenzothiazole (BTZ), 2-pyridinylbenzoxazole (BOZ) & 2-pyridinylbenzimidazole (BIZ) scaffolds

  2016cites this paper
• Rhodium(III) and iridium(III) pentamethylcyclopentadienyl complexes with tris(2-carboxyethyl)phosphine, properties and cytostatic activity

  2016cites this paper
• Synthesis of 5-acetyl-2-arylamino-4-methylthiazole Thiosemicarbazones under Microwave Irradiation and their in Vitro Anticancer Activity

  2016cites this paper
• Synthesis and structural studies of arene ruthenium and Cp*Rh/Cp*Ir complexes containing pyridylpyrazole- and pyridylthiazole-based ligands

  2016cites this paper
• Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.

  2016cites this paper
• Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity.

  2016cites this paper
• DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents.

  2015cites this paper
• A Half-Sandwich Rhodium(III) Complex with 4-Bromo-N-(1-Pyrenylidene)Aniline: Regioselective Cyclorhodation of the 1-Pyrenyl Group

  2015cites this paper
• Synthesis, Spectroscopic and Molecular Studies of Half‐Sandwich η6‐Arene Ruthenium, Cp* Rhodium and Cp* Iridium Metal Complexes with Bidentate Ligands

  2015cites this paper
• Study of Conversion of Polymeric Organophosphorus Ylide Complexes of Mercury(II) Halides to Phenazine Complexes: X-Ray Crystal Structures and Spectral Characterizations

  2015cites this paper
• Ruthenium complexes as inhibitors of the aldo-keto reductases AKR1C1-1C3.

  2015cites this paper
• Organometallic rhodium(III) and iridium(III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands.

  2015cites this paper
• Diaminohexopyranosides as Ligands in Half-Sandwich Ruthenium(II), Rhodium(III), and Iridium(III) Complexes

  2015cites this paper
• Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.

  2015cites this paper
• Mononuclear half-sandwich cyclic-π-perimeter platinum group metal complexes having bithiazole ligands: Synthesis, molecular and anti-cancer studies

  2014cites this paper
• The Potent Oxidant Anticancer Activity of Organoiridium Catalysts

  2014cites this paper
• Organoiridium Complexes: Anticancer Agents and Catalysts

  2014cites this paper
• Ferrocenes as potential anticancer drugs. Facts and hypotheses

  2014cites this paper
• Half-sandwich η 6 -arene ruthenium and Cp ∗ rhodium/iridium compounds comprising with thioether ligands: Synthesis, spectral and molecular studies

  2014cites this paper
• Synthesis and evaluation of new polynuclear organometallic Ru(II), Rh(III) and Ir(III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents.

  2014cites this paper
• Synthesis, characterization, interactions with DNA and bovine serum albumin (BSA), and antibacterial activity of cyclometalated iridium(III) complexes containing dithiocarbamate derivatives

  2014cites this paper
• Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C∧N-Chelated and Pyridine Ligands

  2014cites this paper
• Palladium-catalyzed C-2 selective olefination of thiazoles.

  2014cites this paper
• Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.

  2014cites this paper
• Anticancer Potential of (Pentamethylcyclopentadienyl)chloridoiridium(III) Complexes Bearing κP and κP,κS‐Coordinated Ph2PCH2CH2CH2S(O)xPh (x=0–2) Ligands

  2014cites this paper
• Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes.

  2014cites this paper
• Formation of glutathione sulfenate and sulfinate complexes by an organoiridium(III) anticancer complex

  2014cites this paper
• Synthesis, characterization and in vitro cytotoxic properties of new silver(I) complexes of two novel Schiff bases derived from thiazole and pyrazine

  2014cites this paper
• Cyclometalated rhodium(III) complexes bearing dithiocarbamate derivative: Synthesis, characterization, interaction with DNA and biological study

  2014cites this paper
• Highly cytotoxic trithiolato-bridged dinuclear Rh(III) and Ir(III) complexes

  2014cites this paper
• Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.

  2014cites this paper
• Cadmium complexes and cocrystals of indium complexes of benzothiazole derivatives and anticancer activities of the cadmium complexes

  2013cites this paper
• Development and characterization of pro-apoptotic drug candidates for anticancer drug discovery

  2013cites this paper
• Organometallic Complexes of Pyridines Together with Diverse Heterocycles as Ligands

  2013cites this paper
• Neutral and cationic multinuclear half-sandwich rhodium and iridium complexes coordinated to poly(propyleneimine) dendritic scaffolds: synthesis and cytotoxicity

  2013cites this paper
• Dual C–H activations of electron-deficient heteroarenes: palladium-catalyzed oxidative cross coupling of thiazoles with azine N -oxides

  2013cites this paper
• Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.

  2013cites this paper
• Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.

  2013cites this paper
• Effect of pH on the photophysical properties of two new carboxylic-substituted iridium(III) complexes.

  2013cites this paper
• DNA binding and anti-cancer activity of redox-active heteroleptic piano-stool Ru(II), Rh(III), and Ir(III) complexes containing 4-(2-methoxypyridyl)phenyldipyrromethene.

  2013cites this paper
• Synthesis and in vitro antitumor activity of novel iridium(III) complexes with enantiopure C2-symmetrical vicinal diamine ligands.

  2013cites this paper
• Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.

  2013cites this paper
• Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts

  2012cites this paper
• Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.

  2012cites this paper
• Syntheses and structural studies of mononuclear arene ruthenium complexes with nitrogen-based chelating ligands

  2012cites this paper